The Vaccine Book (3rd Ed.) New Insights, Approaches, and Technologies
Coordonnateurs : Bagnoli Fabio, Rappuoli Rino, Phogat Sanjay
The Vaccine Book: New Insights, Approaches and Technologies, Third Edition?provides comprehensive information on the current and future world of vaccines. It reveals the scientific opportunities and potential impact of vaccines, including economic and ethical challenges, problems encountered when producing vaccines, how clinical vaccine trials are designed, and how to introduce vaccines into widespread use. Although vaccines are now available for many diseases, there are still challenges ahead for major diseases such as AIDS, tuberculosis, and malaria. Edited by a new, highly experienced team of editors, the 3rd edition provides new approaches, design, and vaccine platform tools to develop vaccines quicker. This new edition is fully updated and designed for students, researchers, public health offcials, and all others interested in increasing their understanding of vaccines.
1. Currently available viral vaccines, their targets and technologies
2. Currently available bacterial & parasite vaccines, their targets and technologies
3. Immunology behind mechanism of action of vaccines
4. Adjuvants and their use in vaccines
5. Vaccine discovery approaches and tools
6. Vaccine development, regulatory path and launch in the market
7. Health economics of vaccines
8. COVID-19: a disaster and a revolution
Part II: New vaccines and technologies for addressing unmet medical needs???
9. Key vaccines still lacking globally and their potential impact (including AMR)
10. New approaches and tools for discovering vaccines
11. New technologies and tools for designing vaccines
12. New vaccine platforms technologies: mRNA, DNA, viral vectors, OMV, bioconjugates.
13. Technical, manufacturing, regulatory and development aspects of mRNA-based vaccines
14. Faster ways for developing vaccines
15. Getting ready to next pandemics
Rino Rappuoli?is Senior Vice President, Head of Vaccine Research and Development at GSK. Previously, he served as visiting scientist at?Rockefeller University?and?Harvard Medical School?and held roles at Sclavo, Vaccine Research and CSO, Chiron Corporation, and?Novartis?Vaccines. He is Chief Scientist and Head External R&D, GSK Vaccines and has served as visiting scientist at Rockefeller University and Harvard Medical School. He is an elected member of the US National Academy of Sciences and the European Molecular Biology Organization. His awards include the Paul Ehrlich and Ludwig Darmstaedter Prize (1991), Italian President Gold Medal (2005), Albert Sabin Gold Medal (2009). In 2013 he was nominated third most influential person worldwide in the field of vaccines (Terrapin). In 2015 he was awarded Fellowship of Imperial College Faculty of Medicine London and the Maurice Hilleman Award.
Sanjay Phogat is Vice President at GSK, Research & Development. He is the Discovery Performance Unit (DPU) head. As DPU head along with his team, he drives the discovery portfolio which includes bacterial, fungal vaccines, and monoclonal antibodies against infectious diseases. Sanjay is an infectious diseases expert with over twenty years of experience and a strong understa
- Includes new vaccines and current concepts as well as vaccine developments to prepare for new pandemics
- Provides insights into diseases that could be prevented, along with the challenges facing research scientists in the world of vaccines
- Delivers ideas about challenges facing public and private industrial investors in the vaccine area
- Discusses the problem of declining immunization rates and vaccine hesitancy
Date de parution : 12-2024
Ouvrage de 700 p.
15x22.8 cm
Thèmes de The Vaccine Book :
Mots-clés :
Vaccine; pandemic; COVID-19; adjuvants; bionconjugates; mRNA; DNA; vaccine development
